Bluefin Capital Management »

Inhibrx Biosciences shares owned by Bluefin Capital Management

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Bluefin Capital Management from 13F filings

Historical chart of Bluefin Capital Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Bluefin Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Bluefin Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $289k 19k 15.66
2024-06-30 $472k 33k 14.17

More positions owned by Bluefin Capital Management

Chesapeake Energy Corp *w Exp 02/09/202 (EXEEL)
Sprott Physical Gold & Silve Tr Unit (CEF)
United States Steel Corporation Call Option (X)
Capri Holdings SHS Call Option (CPRI)
Alphabet Cap Stk Cl C (GOOG)
Spdr Gold Tr Gold Shs (GLD)
Energy Transfer Com Ut Ltd Ptn (ET)
Powerschool Holdings Com Cl A
Star Hldgs Shs Ben Int (STHO)
Microstrategy Cl A New (MSTR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Hess Put Option (HES)
Albertsons Cos Common Stock (ACI)
Endeavor Group Hldgs Cl A Com (EDR)
Sprott Physical Silver Tr Tr Unit (PSLV)

View all positions for Bluefin Capital Management

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Walleye Trading Advisors
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Millennium Management
Geode Capital Management
Caption Management
Kennedy Capital Management
State Street Corporation
Arrowpoint Asset Management
Susquehanna International
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences